Oncology
David Gerber, M.D.
Professor of Internal Medicine (Hematology-Oncology) and Population & Data Sciences; Associate Director for Clinical Research, Harold C. Simmons Comprehensive Cancer Center; Co-Leader, Experimental Therapeutics Program
David E. Gerber, MD, is a medical oncologist specializing in thoracic oncology, particularly lung cancer, at UT Southwestern Medical Center in Dallas, Texas. He treats patients with advanced solid tumor malignancies, including non-small cell lung cancer, primary pericardial mesothelioma, and other thoracic cancers. His practice emphasizes targeted therapies, novel agents, and precision medicine approaches, as evidenced by his leadership in clinical trials such as bavituximab for solid tumors, ro
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABIM)
- Internal Medicine (ABIM)
Education & Training
- Weill Medical College of Cornell University — M.D., 2000
- UT Southwestern Medical Center — Residency, Internal Medicine, 2000-2003
- Johns Hopkins Hospital — Fellowship, Medical Oncology, 2004-2007
Peer Recognition
- Castle Connolly — Top Doctor
2017-2026 (10 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- William P. Clements Jr. University Hospital
- UT Southwestern Medical Center
- Harold C. Simmons Comprehensive Cancer Center
Languages
English
Experience
25+ years in practice